CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets +2 moredrug
Likely dose
Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tabletsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04425863
NCT04425863N/ACompleted
CompareCT.gov

Evaluation of Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of covid19

Eurnekian Public Hospital·observational·Posted Jun 11, 2020·Updated Oct 19, 2020

In Brief

An observational study evaluating Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets, Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets, and 1 other intervention for Severe Acute Respiratory Syndrome and Ventilation Pneumonitis. Completed, enrolled 167 participants across 1 site.

Detailed Summary

The associated use of Ivermectin, aspirin, dexamethasone, and enoxaparin (in different combinations and doses) will reduce the impact of COVID infection 19, the need of admission to the intensive care unit, and mortality.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Acute Respiratory Syndrome, Ventilation Pneumonitis
CountriesArgentina
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 11, 2020
Enrollment StartMay 1, 2020
Primary CompletionAug 30, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.1 years ago

Interventions

Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tabletsdrug

24 mg oral Ivermectin on days 0 and 7 and 1 Aspirin tablet daily for 30 days. Outpatient treatment.

Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tabletsother

36 mg oral Ivermectin on days 0 and 7; 1 daily injection of 4-mg Dexamethasone until discharge, 1 Aspirin tablet daily for 30 days. Inpatient treatment in ward care, including Low flow washed oxygen or oxygen concentrator

Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.other

48 mg oral Ivermectin on days 0 and 7; 1 daily injection of 4-mg Dexamethasone until discharge, Enoxaparin 100 IU/kg (ca. 1 mg/kg) daily until transfer to ward care. Then continue with inpatient treatment in ward care.